Antibody Tests Go To Market Largely Unregulated, Warns House Subcommittee Chair
Most coronavirus antibody test-makers are choosing to skip FDA verification, says Raja Krishnamoorthi of the House Subcommittee on Economic and Consumer Policy.
by Hannah Hagemann
Apr 26, 2020
1 minute
Coronavirus antibody tests have garnered attention from officials as a potential tool to evaluate people's immunity to the illness. But the majority of companies creating the tests have had little to no regulatory oversight, according to the chair of the House Subcommittee
You’re reading a preview, subscribe to read more.
Start your free 30 days